These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10145140)

  • 1. Estimating treatment cost functions for progressive diseases: a multiproduct approach with an application to breast cancer.
    Butler JR; Furnival CM; Hart RF
    J Health Econ; 1995 Aug; 14(3):361-85. PubMed ID: 10145140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The costs of treating breast cancer in Australia and the implications for breast cancer screening.
    Butler JR; Furnival CM; Hart RF
    Aust N Z J Surg; 1995 Jul; 65(7):485-91. PubMed ID: 7611968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost utility analysis of mammography screening in Australia.
    Hall J; Gerard K; Salkeld G; Richardson J
    Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower costs of hospital treatment of breast cancer through a population-based mammography screening programme.
    Kauhava L; Immonen-Räihä P; Parvinen I; Helenius H; Kaljonen A; Räsänen O; Pylkkänen L; Klemi PJ
    Eur J Public Health; 2004 Jun; 14(2):128-33. PubMed ID: 15230496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Will early detection of breast cancer reduce the costs of treatment?
    Salkeld G; Gerard K
    Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of treating breast cancer in the United Kingdom: implications for screening.
    Wolstenholme JL; Smith SJ; Whynes DK
    Int J Technol Assess Health Care; 1998; 14(2):277-89. PubMed ID: 9611903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
    Elixhauser A
    Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic aspects of MR-mammography in dense breasts.
    Kaiser CG; Reich C; Wasser K; Schönberg SO; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S69-71. PubMed ID: 23083609
    [No Abstract]   [Full Text] [Related]  

  • 10. Financial facts about treating breast cancer.
    Smith MD; McGhan WF
    Bus Health; 1996 Dec; 14(12):67-8, 70. PubMed ID: 10163993
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
    Li Y; Arellano AR; Bare LA; Bender RA; Strom CM; Devlin JJ
    Value Health; 2017 Apr; 20(4):547-555. PubMed ID: 28407996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors.
    Neeser K; Szucs T; Bulliard JL; Bachmann G; Schramm W
    Value Health; 2007; 10(1):42-53. PubMed ID: 17261115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-benefit analysis of a mammography screening program extended to all the national territory].
    Vanara F; Zappa M; Rosselli del Turco M; Segnan N; Paci E; Ponti A
    Epidemiol Prev; 1997; 21(2):118-28. PubMed ID: 9378179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway.
    Moger TA; Bjørnelv GM; Aas E
    Eur J Health Econ; 2016 Jul; 17(6):745-54. PubMed ID: 26239280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.
    Szeto KL; Devlin NJ
    Health Policy; 1996 Nov; 38(2):101-15. PubMed ID: 10160378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.
    Trentham-Dietz A; Ergun MA; Alagoz O; Stout NK; Gangnon RE; Hampton JM; Dittus K; James TA; Vacek PM; Herschorn SD; Burnside ES; Tosteson ANA; Weaver DL; Sprague BL
    Breast Cancer Res Treat; 2018 Feb; 168(1):229-239. PubMed ID: 29185118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer.
    Streitz JM; Ellis FH; Tilden RL; Erickson RV
    Am J Gastroenterol; 1998 Jun; 93(6):911-5. PubMed ID: 9647017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.